© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
A Business’s Guide To Shipping Overseas For The First Time
News
01/08/2022A Business’s Guide To Shipping Overseas For The First Time

Today, business operations are scaling new heights. Thanks to digitization and globalization, business owners can now transact globally without hassle. As part of the growth in the business industry, you can ship goods overseas for your global clients. However

Read Full PostRead - Eye Icon
Simplified Skype for Business in Traditional Video Conferencing Environments
Innovation
09/11/2015Simplified Skype for Business in Traditional Video Conferencing Environments

Cyviz, a leader in visual collaboration and command and control systems, today announced that the company has developed a more intuitive, user-friendly way to incorporate the use of Microsoft’s Skype for Business (formerly Lync) in traditional video conferen

Read Full PostRead - Eye Icon
GLOBALFOUNDRIES Acquires IBM’s Microelectronics
M&A
15/12/2014GLOBALFOUNDRIES Acquires IBM’s Microelectronics

We spoke to Marco Chisari, Head of Corporate Development and M&A at GLOBALFOUNDRIES, to find out more about the deal

Read Full PostRead - Eye Icon
Digital Strategy 101: The Basics in Developing And Modernising Your Business
News
02/09/2022Digital Strategy 101: The Basics in Developing And Modernising Your Business

Many businesses were moving towards digital transformation but this transformation has been sped up by the Covid pandemic. Worth some $469.8 billion in 2020, the market is expected to grow to $1,009.8 billion by 2025. That means many organisations are looking

Read Full PostRead - Eye Icon
What works best: HTML email marketing or plain text?
News
15/06/2022What works best: HTML email marketing or plain text?

Email marketing is a powerful tool to reach more people, increase engagement, and generate more leads. There are two ways to send an email to your marketing list, one is to spruce it up using HTML and the other is to keep is simple with plain text. Which one w

Read Full PostRead - Eye Icon
Serving Up Five-Star Event Experiences for C-Level Decision Makers
Innovation
23/03/2020Serving Up Five-Star Event Experiences for C-Level Decision Makers

When a business needs to secure new leads and generate new work, there are few more appealing methods to garner a potential client’s attention than with dinner, a carefully-curated presentation, and plenty of networking. Offering some of the biggest corporat

Read Full PostRead - Eye Icon
Intellectual Property Rights – Four Top Tips
Innovation
05/12/2022Intellectual Property Rights – Four Top Tips

The protection and maintenance of a business' intellectual property (IP) is often overlooked and misunderstood by business owners. The IP of a business is a valuable asset, and in the correct circumstances can be utilised to help generate additional income wit

Read Full PostRead - Eye Icon
An Inside Look at AI’s Most  Outstanding Strategic  Communications Team
Strategy
26/06/2017An Inside Look at AI’s Most Outstanding Strategic Communications Team

As the head of strategic communications firm Sharon Merrill Associates, Maureen Wolff has received more than her share of 3 a.m. phone calls from anxious CEOs and board members. And she remembers every one of them. The arson at a document storage facility.

Read Full PostRead - Eye Icon
Overall CEO of the Year, the USA
Innovation
01/04/2016Overall CEO of the Year, the USA

BROWZ is a software as a service (SaaS) solution provider of supply chain qualification and risk management. In today’s economic environment, most large organizations outsource work to contractors.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow